L'IMPERIO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 9.452
AS - Asia 8.247
EU - Europa 6.202
SA - Sud America 1.198
AF - Africa 149
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 25.271
Nazione #
US - Stati Uniti d'America 9.175
SG - Singapore 3.514
IT - Italia 2.049
CN - Cina 1.704
VN - Vietnam 1.167
HK - Hong Kong 997
RU - Federazione Russa 990
BR - Brasile 959
DE - Germania 789
SE - Svezia 628
IE - Irlanda 470
GB - Regno Unito 253
KR - Corea 171
AT - Austria 162
FR - Francia 162
CA - Canada 156
IN - India 150
ID - Indonesia 138
FI - Finlandia 137
UA - Ucraina 115
NL - Olanda 114
AR - Argentina 91
MX - Messico 88
TR - Turchia 72
PL - Polonia 71
DK - Danimarca 67
BD - Bangladesh 64
ZA - Sudafrica 64
JP - Giappone 58
IQ - Iraq 46
ES - Italia 39
EC - Ecuador 36
PK - Pakistan 33
LT - Lituania 29
BE - Belgio 26
CO - Colombia 23
MA - Marocco 20
UY - Uruguay 19
VE - Venezuela 19
CH - Svizzera 18
PY - Paraguay 18
SA - Arabia Saudita 18
AU - Australia 17
PE - Perù 16
AE - Emirati Arabi Uniti 15
GR - Grecia 15
TN - Tunisia 15
CL - Cile 13
EG - Egitto 13
PT - Portogallo 13
PH - Filippine 12
UZ - Uzbekistan 10
JO - Giordania 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
KE - Kenya 8
AL - Albania 7
DO - Repubblica Dominicana 7
CR - Costa Rica 6
DZ - Algeria 6
IL - Israele 6
IR - Iran 6
LV - Lettonia 6
PA - Panama 6
RS - Serbia 6
BG - Bulgaria 5
HU - Ungheria 5
JM - Giamaica 5
LB - Libano 5
TH - Thailandia 5
TW - Taiwan 5
BO - Bolivia 4
BY - Bielorussia 4
KZ - Kazakistan 4
MY - Malesia 4
NO - Norvegia 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AM - Armenia 3
AO - Angola 3
GA - Gabon 3
GE - Georgia 3
OM - Oman 3
SC - Seychelles 3
SV - El Salvador 3
BH - Bahrain 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
Totale 25.256
Città #
Singapore 1.911
Ann Arbor 1.477
Ashburn 1.168
Hong Kong 986
Milan 616
Frankfurt am Main 476
Dublin 452
Dallas 419
Hefei 411
Fairfield 386
Ho Chi Minh City 371
Chandler 346
New York 328
San Jose 320
Santa Clara 319
Los Angeles 307
Wilmington 291
Hanoi 282
Beijing 248
Houston 226
Woodbridge 219
Seattle 164
Seoul 157
Princeton 134
Dearborn 133
Buffalo 122
The Dalles 119
Cambridge 114
São Paulo 110
Jakarta 106
Shanghai 103
Vienna 102
Moscow 95
Munich 82
Jacksonville 81
Chicago 78
Helsinki 69
London 67
Warsaw 63
Rome 62
Nanjing 60
Denver 56
Dong Ket 54
Kent 53
Nuremberg 53
Altamura 52
Lawrence 50
Montreal 48
Guangzhou 46
Tokyo 46
Orem 45
Da Nang 43
Toronto 40
Chennai 39
Stockholm 39
Florence 38
Johannesburg 38
Monza 34
Poplar 34
Phoenix 33
Boardman 32
Hải Dương 32
Atlanta 31
Salt Lake City 31
Mexico City 30
Brooklyn 29
Council Bluffs 29
Lissone 29
Haiphong 28
Lappeenranta 28
Ha Long 27
Turku 27
Naples 26
Rio de Janeiro 26
Pune 25
Boston 24
Nanchang 24
Amsterdam 23
Brussels 23
Istanbul 23
San Diego 23
Bologna 22
Cinisello Balsamo 22
Manchester 22
Turin 22
Ankara 19
Biên Hòa 19
Changsha 19
Shenyang 19
Zhengzhou 19
Falls Church 18
Thái Nguyên 18
Tianjin 18
Bari 17
Düsseldorf 17
Ottawa 17
Quito 17
Quận Bình Thạnh 17
Sesto San Giovanni 17
Andover 16
Totale 15.346
Nome #
The putative role of MALDI-MSI in the study of Membranous Nephropathy 391
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 357
MALDI imaging in Fabry nephropathy: a multicenter study 357
The proteomic landscape of renal tumors 354
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 353
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 350
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 338
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 331
Kidney Involvement 325
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 325
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 317
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 313
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 306
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 300
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 294
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 291
Proteomics for the study of new biomarkers in Fabry disease: State of the art 290
"Pathologists in Venice - Real World Cases for an Immersive Training Experience": Education, Gaming, and Show 282
Proteome analysis in thyroid pathology 273
PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols 272
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 268
Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use case 264
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 262
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline 252
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 250
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 248
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 246
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 244
Debating the pros and cons of computational pathology at the European Congress of Pathology (ECP) 2024 240
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 239
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 233
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 233
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 232
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 229
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 224
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 224
Immunosuppression in idiopathic membranous nephropathy: A double-edge sword 223
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 214
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 212
Digital transition in pathology lab: a survey from the Lombardy region 206
Displaced Cartilage Within Lymph Node Parenchyma Is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA 205
More than an ‘atypical’ phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy 202
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 200
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 198
Improvements in digital pathology equipment for renal biopsies: updating the standard model 197
MALDI-MS imaging in the study of glomerulonephritis 197
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 195
The Complex Cyto-Molecular Landscape of Thyroid Nodules in Pediatrics 193
The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy 192
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 188
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 187
Anticoagulant-related nephropathy: a pathological note 187
The role of digital and integrative pathology for the detection of translocations: a narrative review 183
Goodpasture syndrome and anti-glomerular basement membrane disease 182
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM 180
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 180
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 178
Tumour incidence in Fabry disease: A cross-sectional study 178
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 178
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 176
An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma 175
Kidney Function, CKD Causes, and Histological Classification 174
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 173
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 171
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 169
Digital pathology for the routine diagnosis of renal diseases: a standard model 169
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 168
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis 166
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 166
The putative role of MALDI-MSI in the study of Membranous Nephropathy 166
The putative role of MALDI-MSI in the study of Membranous Nephropathy 166
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 165
#EBUSTwitter: Novel use of social media for conception, coordination, and completion of an international, multicenter pathology study 165
Artificial intelligence–based algorithms for the diagnosis of prostate cancer: A systematic review 161
Enhancing proteomics characterization of thyroid nodules: a pixel-classifier for mass spectrometry imaging analyses 161
Liquid-based shaking of core needle biopsy samples for the molecular characterization of tumors: A fallback in cytopathology 160
Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification 156
Autopsia di Innocenzo XII. Un’attestazione dell’utilizzo del microscopio in ambito necroscopico nel XVII secolo 155
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 155
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 154
The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective 154
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 152
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 151
Digital twin manifesto for the pathology laboratory 151
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 150
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 150
Renal involvement in eosinophilic granulomatosis with polyangiitis 149
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 149
Automate the process of formalin-fixed paraffin-embedded blocks storage in the pathology laboratory: A proof of concept study 143
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 143
Digital Pathology Applications for PD-L1 Scoring in Head and Neck Squamous Cell Carcinoma: A Challenging Series 143
Response to: 'Correspondence on 'Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications'' by Hakroush and Tampe 142
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 141
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 141
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 141
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 140
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 138
Cost analysis of archives in the pathology laboratories: from safety to management 138
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 137
Systemic vasculitis involving the kidney: the nephropathologist's point of view 136
Totale 21.122
Categoria #
all - tutte 86.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021958 0 0 0 0 0 0 166 198 148 159 120 167
2021/20221.189 145 131 127 68 68 101 26 79 33 83 123 205
2022/20231.928 185 503 193 146 106 275 53 144 164 41 81 37
2023/20241.950 67 85 86 121 190 442 351 70 175 40 87 236
2024/20256.832 234 517 624 277 469 287 329 219 645 1.000 884 1.347
2025/20269.996 1.962 1.303 1.414 2.009 1.864 832 612 0 0 0 0 0
Totale 25.935